Cite
MLA Citation
Tony Reid et al.. “Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study.” Lancet oncology, vol. 16, no. 9, n.d., pp. 1133–1142. http://access.bl.uk/ark:/81055/vdc_100051217362.0x000030